Pune, India -- (SBWire) -- 11/16/2018 --The Cancer Vaccine Market was worth USD 3959.9 Million in 2017 and is projected to reach around USD 12433.5 Million by 2024. The Cancer Vaccine Market is estimated to grow at a CAGR of 17.76% during the forecast period, 2018-2024. The North America region accounted for the highest market share of approximate 49.5% in 2017 and is expected to remain dominant through the forecast period. The Asia-Pacific region is expected to grow at CAGR of 18.25% during the forecast period.
For More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1096
Our latest research report entitled Cancer Vaccines Market (by technology (whole cell, dendritic cells, antigen/adjuvant, and recombinant, viral vector cancer vaccines), type (preventive, therapeutic cancer vaccines), indication (prostate, cervical cancer), and end user (adult, pediatric vaccine)) provides complete and deep insights into the market dynamics and growth of Cancer Vaccines. Latest information on market risks, industry chain structure Cancer Vaccines cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential Cancer Vaccines growth factors.
The forecast Cancer Vaccines Market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Cancer Vaccines on global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report.
Segments Mentioned in this Premium Report
The report on global cancer vaccines market covers segments such as technology, type, indication, and end user. The technology segments include whole cell cancer vaccine, dendritic cells cancer vaccines, antigen/adjuvant cancer vaccines, recombinant cancer vaccines, and viral vector & DNA cancer vaccines. On the basis of type the global cancer vaccines market is categorized into preventive cancer vaccines and therapeutic cancer vaccines. Furthermore, on the basis of indication the cancer vaccines market is segmented as prostate cancer, cervical cancer and others. On the basis of end user the cancer vaccines market is segmented as adult vaccines and pediatric vaccine.
For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1096
Major Key Players mentioned in this Premium Report
The report provides profiles of the companies in the global cancer vaccines market such as, Glaxosmithkline Plc, Aduro BioTech Inc., Astellas Pharma Inc., Merck & Co., Inc., CSL Limited, Sanpower Group, Sanofi Pasteur, Pfizer Inc, Serum Institute of India Pvt. Ltd., and Others.
The Cancer Vaccine Market Is Estimated to Grow at a CAGR of 17.76% During the Forecast Period, to Reach a Market Size of USD 12.43 Billion by 2024
The Cancer Vaccine Market was worth USD 3959.9 Million in 2017 and is projected to reach around USD 12433.5 Million by 2024